Jan 25, 2025, 15:21
Learning hematology in 2025 with Nico Gagelmann: Part 2
Nico Gagelman is a physician and scientist who co-founded and co-chairs the European Society for Blood and Marrow Transplantation (EBMT) Trainee Committee, and he also serves as the chair of the EBMT subcommittee focused on CAR-T cell therapies for plasma cell disorders.
His work is particularly impactful in the realm of CAR-T treatments for multiple myeloma, where he has contributed to advancing research and clinical approaches.
Recently Nico Gagelmann began a new series on X titled ‘Let’s Learn Hematology in 2025.’ Here’s part 2 of his educational journey:
“Differential of anemia, simplified.”
“Causes of bleeding, simplified.”
“First description of sickle cell disease in 1910.”
“Drug approvals in hematology in 2024.”
“Anemia management in older patients.”
“Erdheim-Chester disease features.”
“Human leukocyte antigen complex.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 25, 2025, 07:25
Feb 25, 2025, 07:16
Feb 25, 2025, 06:51
Feb 24, 2025, 23:27
Feb 24, 2025, 15:25
Feb 24, 2025, 14:55
Feb 24, 2025, 14:51
Feb 24, 2025, 14:45